Hospital Universitario Mutua de Terrassa

Terrassa 08222

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer Stage II, Colorectal Cancer Stage III, Gastric Cancer

Studies at this site

• Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy — Completed
• A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer — Completed